Stay updated on Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision: v3.4.3 removed and Revision: v3.5.0 added.
    Difference
    0.0%
    Check dated 2026-03-21T01:07:26.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T18:41:11.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no substantive content changes are visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:57:12.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now displayed, replacing v3.4.0; core information and study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T18:57:02.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page shows Revision: v3.3.4 as an addition and Revision: v3.3.3 as removed, indicating a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:28:00.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Updated the study locations to include new sites in the United States (Arizona, Colorado, Kansas, Kentucky, Louisiana, New Hampshire, North Carolina, Ohio, Tennessee, Washington) and international sites (Buenos Aires, Mexico City, Nuevo León, San Luis Potosí, Sinaloa, Yucatán, Lesser Poland Voivodeship, Kemerovo Oblast, Novosibirsk Oblast, Tomsk Oblast, La Coruna, Malaga, Vizcaya). Some locations that appeared in the previous revision were removed.
    Difference
    2%
    Check dated 2025-12-24T14:12:44.000Z thumbnail image

Stay in the know with updates to Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.